Keeping Pace With the Evolving Treatment Landscape in Idiopathic Pulmonary Fibrosis

Supplements and Featured Publications, Keeping Pace With the Evolving Treatment Landscape in Idiopathic Pulmonary Fibrosis, Volume 21, Issue 14

Publishing Staff

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Director

Christina Doong

Proofreaders

Maggie ShawGriselda Demassey

Associate Editor

Jeanne Linke

Clinical Editor

Michael R. Page, PharmD, RPh

Designer

Julianne Costello

Associate Publisher

Justin Gallagher

Director of Sales

Sara Stewart

National Account Managers

Gabrielle ConsolaMichael Costella

Corporate Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping

Chief Operating Officer/CFO

Neil Glasser, CPA/CFE

President, Managed Markets

Brian Haug

Executive Vice President and General Manager

John Maglione

Human Resources Director

Shari Lundenberg

Chief Creative Officer

Jeff Brown

President of Pharmacy Times Office of Continuing Professional Education

David Heckard

Participating FacultyFaculty

Maria Padilla, MD

Professor of Medicine Director of Interstitial Lung Disease Program

The Icahn School of Medicine at Mount Sinai

New York, New York

Thomas J. Morrow, MD

Chief Medical Officer

Next IT

Spokane, Washington

Editorial Support

Priya Karkhanis

Scientific Consultant

Hillsborough, New Jersey

Christine Sokoloski

Medical Writer

Hillsborough, New Jersey

Debra Gordon

President GordonSquared, Inc

Williamsburg, Virginia

Faculty Disclosures

Maria L. Padilla, MD (author) has relevant financial relationships with commercial interests as follows:

Boehringer Ingelheim: Consultant/Speakers’ bureau, received consultation/speaker fee

Genentech: Speakers’ bureau with honoraria

Thomas J. Morrow, MD (author) has relevant financial relationships with commercial interests as follows:

Genentech: Stock ownership, no fee received

Editorial Support Disclosures

Debra Gordon (editorial support) has relevant financial relationships with commercial interests as follows:

Merck: Stock ownership, no fee received; husband employed by Merck

Priya Karkhanis (editorial support) and Christine Sokoloski (editorial support) have no relevant financial relationships with commercial interests to disclose.